Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19072799 | 1.00 | SLC22A1 (0.37) | SLC22A1OPRM1HTR2AHRH1TDP1 | |
| SCHEMBL20074403 | 0.85 | SLC22A1 (0.36) | SLC22A1OPRM1 | |
| SCHEMBL8756248 | 0.80 | SLC22A1 (0.34) | SLC22A1OPRM1 | |
| SCHEMBL15314156 | 0.77 | SLC22A1 (0.32) | SLC22A1OPRM1 | |
| SCHEMBL19432943 | 0.77 | — | — | |
| SCHEMBL24179178 | 0.77 | PIK3CD (0.31) | — | |
| SCHEMBL21375563 | 0.77 | HTR2A (0.32) | SLC22A1OPRM1HTR2AHRH1TDP1 | |
| SCHEMBL24324108 | 0.77 | SLC22A1 (0.32) | SLC22A1OPRM1 | |
| SCHEMBL18848833 | 0.77 | PIK3CD (0.31) | — | |
| SCHEMBL15142570 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190016879-A1 | WATER REPELLENT COMPOSITION AND PROCESS FOR PRODUCING MOISTURE PERMEABLE WATERPROOF FILM COATED ARTICLE | AGC Inc. (JP) | 2019-01-17 | — | — | US | disclosed |
| US-20170233330-A1 | Process for the preparation of 3-[(1R,2R)-3-(Dimethylamino)-1-ethyl-2-methylpropyl]-phenol | SANDOZ AG (CH) | 2017-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170233330-A1 | Process for the preparation of 3-[(1R,2R)-3-(Dimethylamino)-1-ethyl-2-methylpropyl]-phenol | AGTR1, SAT1, TMT1A | SLC22A1 1704/4885OPRM1 1153/4885HTR2A 1978/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.